Hooked! modeling human disease in zebrafish

Journal of Clinical Investigation

Volumn 122, Issue 7, 2012, Pages 2337-2343

  Santoriello, Cristina ^a   Zon, Leonard I ^a,b,c  

^a HARVARD UNIVERSITY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; CENTRAL NERVOUS SYSTEM DISEASE; DISEASE COURSE; DISEASE MODEL; EYE DISEASE; HEART DISEASE; HEMATOLOGIC DISEASE; HUMAN; KIDNEY DISEASE; MUSCLE DISEASE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; TRANSGENICS; ZEBRA FISH;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; DISEASE MODELS, ANIMAL; DRUG SCREENING ASSAYS, ANTITUMOR; EYE DISEASES; FEMALE; GENETIC ENGINEERING; HEART DISEASES; HEMATOLOGIC DISEASES; HUMANS; KIDNEY DISEASES; MALE; MUSCULAR DYSTROPHY, DUCHENNE; NEOPLASMS; ZEBRAFISH;

EID: 84863557893     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI60434     Document Type: Review

References (112)

1. Langheinrich U. Zebrafish: a new model on the pharmaceutical catwalk. Bioessays. 2003;25(9):904-912. (Pubitemid 37081756)
2. Postlethwait J, Amores A, Cresko W, Singer A, Yan YL. Subfunction partitioning, the teleost radiation and the annotation of the human genome. Trends Genet. 2004;20(10):481-490. (Pubitemid 39201068)
3. Amsterdam A, Hopkins N. Mutagenesis strategies in zebrafish for identifying genes involved in development and disease. Trends Genet. 2006;22(9):473-478. (Pubitemid 44233717)
4. Haffter P, et al. The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development. 1996;123:1-36. (Pubitemid 27056733)
5. McGrail M, et al. Somatic mutagenesis with a Sleeping Beauty transposon system leads to solid tumor formation in zebrafish. PLoS One. 2011;6(4):e18826.
6. Lan CC, Leong IU, Lai D, Love DR. Disease modeling by gene targeting using microRNAs. Methods Cell Biol. 2011;105:419-436.
7. Meng X, Noyes MB, Zhu LJ, Lawson ND, Wolfe SA. Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases. Nat Biotechnol. 2008;26(6):695-701. (Pubitemid 351809594)
8. Wienholds E, Plasterk RH. Target-selected gene inactivation in zebrafish. Methods Cell Biol. 2004;77:69-90.
9. Wienholds E, van Eeden F, Kosters M, Mudde J, Plasterk RH, Cuppen E. Efficient target-selected mutagenesis in zebrafish. Genome Res. 2003;13(12):2700-2707. (Pubitemid 37541159)
10. Stemple DL. TILLING--a high-throughput harvest for functional genomics. Nat Rev Genet. 2004;5(2):145-150. (Pubitemid 38160281)
11. Berghmans S, et al. tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc Natl Acad Sci U S A. 2005;102(2):407-412. (Pubitemid 40116780)
12. Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem. 2010;79:181-211.
13. Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD. Genome editing with engineered zinc finger nucleases. Nat Rev Genet. 2011;11(9):636-646.
14. Zhu C, et al. Evaluation and application of modularly assembled zinc-finger nucleases in zebrafish. Development. 2011;138(20):4555-4564.
15. Zhu C, et al. Evaluation and application of modularly assembled zinc-finger nucleases in zebrafish. Development. 2011;138(20):4555-4564.
16. Li T, et al. Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes. Nucleic Acids Res. 2011;39(14):6315-6325.
17. Cermak T, et al. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res. 2011;39(12):e82.
18. Gupta A, Meng X, Zhu LJ, Lawson ND, Wolfe SA. Zinc finger protein-dependent and -independent contributions to the in vivo off-target activity of zinc finger nucleases. Nucleic Acids Res. 2010;39(1):381-392.
19. Kikuta H, Kawakami K. Transient and stable transgenesis using tol2 transposon vectors. Methods Mol Biol. 2009;546:69-84.
20. Suster ML, Kikuta H, Urasaki A, Asakawa K, Kawakami K. Transgenesis in zebrafish with the tol2 transposon system. Methods Mol Biol. 2009;561:41-63.
21. Kawakami K, et al. zTrap: zebrafish gene trap and enhancer trap database. BMC Dev Biol. 2010;10:105.
22. Emelyanov A, Parinov S. Mifepristone-inducible LexPR system to drive and control gene expression in transgenic zebrafish. Dev Biol. 2008;320(1):113-121.
23. Mosimann C, Zon LI. Advanced zebrafish transgenesis with Tol2 and application for Cre/lox recombination experiments. Methods Cell Biol. 2011;104:173-194.
24. Scott EK, et al. Targeting neural circuitry in zebrafish using GAL4 enhancer trapping. Nat Methods. 2007;4(4):323-326. (Pubitemid 46766976)
25. Patton EE, et al. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol. 2005;15(3):249-254. (Pubitemid 40205706)
26. Santoriello C, et al. Kita driven expression of oncogenic HRAS leads to early onset and highly penetrant melanoma in zebrafish. PLoS One. 2010;5(12):e15170.
27. Brownlie A, et al. Positional cloning of the zebrafish sauternes gene: a model for congenital sideroblastic anaemia. Nat Genet. 1998;20(3):244-250. (Pubitemid 28507668)
28. Donovan A, et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature. 2000;403(6771):776-781. (Pubitemid 30111839)
29. Shafizadeh E, et al. Characterization of zebrafish merlot/chablis as non-mammalian vertebrate models for severe congenital anemia due to protein 4.1 deficiency. Development. 2002;129(18):4359-4370.
30. Taylor AM, Zon LI. Modeling Diamond Blackfan anemia in the zebrafish. Semin Hematol. 2011;48(2):81-88.
31. van Rooijen E, et al. Zebrafish mutants in the von Hippel-Lindau tumor suppressor display a hypoxic response and recapitulate key aspects of Chuvash polycythemia. Blood. 2009;113(25):6449-6460.
32. Dooley KA, et al. montalcino, A zebrafish model for variegate porphyria. Exp Hematol. 2008;36(9):1132-1142.
33. Montosi G, et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest. 2001;108(4):619-623. (Pubitemid 32777742)
34. Danilova N, Sakamoto KM, Lin S. Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family. Blood. 2008;112(13):5228-5237.
35. Uechi T, Nakajima Y, Chakraborty A, Torihara H, Higa S, Kenmochi N. Deficiency of ribosomal protein S19 during early embryogenesis leads to reduction of erythrocytes in a zebrafish model of Diamond-Blackfan anemia. Hum Mol Genet. 2008;17(20):3204-3211.
36. Tamary H, Alter BP. Current diagnosis of inherited bone marrow failure syndromes. Pediatr Hematol Oncol. 2007;24(2):87-99. (Pubitemid 46594593)
37. Taylor AM, Humphries JM, White RM, Murphey RD, Burns CE, Zon LI. Hematopoietic defects in rps29 mutant zebrafish depend upon p53 activation. Exp Hematol. 2012;40(3):228-237.
38. Linet MS, Ries LA, Smith MA, Tarone RE, Devesa SS. Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst. 1999;91(12):1051-1058. (Pubitemid 29293044)
39. Langenau DM, et al. Myc-induced T cell leukemia in transgenic zebrafish. Science. 2003;299(5608):887-890. (Pubitemid 36182446)
40. Feng H, et al. Heat-shock induction of T-cell lymphoma/leukaemia in conditional Cre/lox-regulated transgenic zebrafish. Br J Haematol. 2007;138(2):169-175. (Pubitemid 46976317)
41. Chen J, Jette C, Kanki JP, Aster JC, Look AT, Griffin JD. NOTCH1-induced T-cell leukemia in transgenic zebrafish. Leukemia. 2007;21(3):462-471.
42. Feng H, et al. T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasation. Cancer Cell. 2010;18(4):353-366.
43. Mizgirev IV, Revskoy S. A new zebrafish model for experimental leukemia therapy. Cancer Biol Ther. 2010;9(11):895-902.
44. Rudner LA, et al. Shared acquired genomic changes in zebrafish and human T-ALL. Oncogene. 2011;30(41):4289-4296.
45. Amatruda JF, Shepard JL, Stern HM, Zon LI. Zebrafish as a cancer model system. Cancer Cell. 2002;1(3):229-231. (Pubitemid 41039146)
46. Liu S, Leach SD. Zebrafish models for cancer. Annu Rev Pathol. 2011;6:71-93.
47. Davies H, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417(6892):949-954. (Pubitemid 34716871)
48. Patton EE, et al. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol. 2005;15(3):249-254. (Pubitemid 40205706)
49. Avery-Kiejda KA, et al. P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation. BMC Cancer. 2011;11:203.
50. Santoriello C, et al. Kita driven expression of oncogenic HRAS leads to early onset and highly penetrant melanoma in zebrafish. PLoS One. 2010;5(12):e15170.
51. Ceol CJ, et al. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature. 2011;471(7339):513-517.
52. Stainier DY, et al. Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development. 1996;123:285-292. (Pubitemid 27056755)
53. Sehnert AJ, Huq A, Weinstein BM, Walker C, Fishman M, Stainier DY. Cardiac troponin T is essential in sarcomere assembly and cardiac contractility. Nat Genet. 2002;31(1):106-110.
54. Xu X, et al. Cardiomyopathy in zebrafish due to mutation in an alternatively spliced exon of titin. Nat Genet. 2002;30(2):205-209.
55. Knöll R, et al. Laminin-alpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells. Circulation. 2007;116(5):515-525. (Pubitemid 47450260)
56. Milan DJ, et al. Drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization. Circulation. 2009;120(7):553-559.
57. Macrae CA. Cardiac Arrhythmia: In vivo screening in the zebrafish to overcome complexity in drug discovery. Expert Opin Drug Discov. 2010;5(7):619-632.
58. Peal DS, et al. Novel chemical suppressors of long QT syndrome identified by an in vivo functional screen. Circulation. 2011;123(1):23-30.
59. Porrello ER, et al. Transient regenerative potential of the neonatal mouse heart. Science. 2011;331(6020):1078-1080.
60. Poss KD, Wilson LG, Keating MT. Heart regeneration in zebrafish. Science. 2002;298(5601):2188-2190. (Pubitemid 35471243)
61. Chablais F, Veit J, Rainer G, Jazwinska A. The zebrafish heart regenerates after cryoinjuryinduced myocardial infarction. BMC Dev Biol. 2011;11:21.
62. Jopling C, Sleep E, Raya M, Marti M, Raya A, Izpisúa Belmonte JC. Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature. 2010;464(7288):606-609.
63. Lepilina A, et al. A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration. Cell. 2006;127(3):607-619. (Pubitemid 44647426)
64. Riley PR, Smart N. Thymosin beta4 induces epicardium-derived neovascularization in the adult heart. Biochem Soc Trans. 2009;37(pt 6):1218-1220.
65. Smart N, et al. De novo cardiomyocytes from within the activated adult heart after injury. Nature. 2011;474(7353):640-644.
66. Bassett DI, Currie PD. The zebrafish as a model for muscular dystrophy and congenital myopathy. Hum Mol Genet. 2003;12 spec no 2:R265-R270. (Pubitemid 37259341)
67. Kawahara G, Karpf JA, Myers JA, Alexander MS, Guyon JR, Kunkel LM. Drug screening in a zebrafish model of Duchenne muscular dystrophy. Proc Natl Acad Sci U S A. 2011;108(13):5331-5336.
68. Asai A, Sahani N, Kaneki M, Ouchi Y, Martyn JA, Yasuhara SE. Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy. PLoS One. 2007;2(8):e806.
69. Swanhart LM, Cosentino CC, Diep CQ, Davidson AJ, de Caestecker M, Hukriede NA. Zebrafish kidney development: basic science to translational research. Birth Defects Res C Embryo Today. 2011;93(2):141-156.
70. Cao Y, Park A, Sun Z. Intraflagellar transport proteins are essential for cilia formation and for planar cell polarity. J Am Soc Nephrol. 2010;21(8):1326-1333.
71. Sun Z, Amsterdam A, Pazour GJ, Cole DG, Miller MS, Hopkins N. A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney. Development. 2004;131(16):4085-4093.
72. van Rooijen E, Giles RH, Voest EE, van Rooijen C, Schulte-Merker S, van Eeden FJ. LRRC50, a conserved ciliary protein implicated in polycystic kidney disease. J Am Soc Nephrol. 2008;19(6):1128-1138.
73. Tobin JL, Beales PL. Restoration of renal function in zebrafish models of ciliopathies. Pediatr Nephrol. 2008;23(11):2095-2099.
74. Diep CQ, et al. Identification of adult nephron progenitors capable of kidney regeneration in zebrafish. Nature. 2011;470(7332):95-100.
75. Brennan CH. Zebrafish behavioural assays of translational relevance for the study of psychiatric disease. Rev Neurosci. 2011;22(1):37-48.
76. Morris AC. The genetics of ocular disorders: insights from the zebrafish. Birth Defects Res C Embryo Today. 2011;93(3):215-228.
77. Newman M, Verdile G, Martins RN, Lardelli M. Zebrafish as a tool in Alzheimer's disease research. Biochim Biophys Acta. 2011;1812(3):346-352.
78. Xi Y, Noble S, Ekker M. Modeling neurodegeneration in zebrafish. Curr Neurol Neurosci Rep. 2011;11(3):274-282.
79. Kokel D, et al. Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat Chem Biol. 2010;6(3):231-237.
80. Rihel J, et al. Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science. 2010;327(5963):348-351.
81. Bibliowicz J, Tittle RK, Gross JM. Toward a better understanding of human eye disease insights from the zebrafish, Danio rerio. Prog Mol Biol Transl Sci. 2011;100:287-330.
82. Lee J, Willer JR, Willer GB, Smith K, Gregg RG, Gross JM. Zebrafish blowout provides genetic evidence for Patched1-mediated negative regulation of Hedgehog signaling within the proximal optic vesicle of the vertebrate eye. Dev Biol. 2008;319(1):10-22.
83. Moosajee M, Gregory-Evans K, Ellis CD, Seabra MC, Gregory-Evans CY. Translational bypass of nonsense mutations in zebrafish rep1, pax2.1 and lamb1 highlights a viable therapeutic option for untreatable genetic eye disease. Hum Mol Genet. 2008;17(24):3987-4000. (Pubitemid 352762859)
84. Neuhauss SC, et al. Genetic disorders of vision revealed by a behavioral screen of 400 essential loci in zebrafish. J Neurosci. 1999;19(19):8603-8615. (Pubitemid 30226778)
85. Lancaster MA, Gleeson JG. The primary cilium as a cellular signaling center: lessons from disease. Curr Opin Genet Dev. 2009;19(3):220-229.
86. Morris AC. The genetics of ocular disorders: insights from the zebrafish. Birth Defects Res C Embryo Today. 2011;93(3):215-228.
87. Ceol CJ, et al. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature. 2011;471(7339):513-517.
88. Norton N, et al. Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. Am J Hum Genet. 2011;88(3):273-282.
89. Weterman MA, et al. A frameshift mutation in LRSAM1 is responsible for a dominant hereditary polyneuropathy. Hum Mol Genet. 2012;21(2):358-370.
90. Bem D, et al. Loss-of-function mutations in RAB18 cause Warburg micro syndrome. Am J Hum Genet. 2011;88(4):499-507.
91. Jiao S, et al. The conserved clusterin gene is expressed in the developing choroid plexus under the regulation of notch but not IGF signaling in zebrafish. Endocrinology. 2011;152(5):1860-1871.
92. O'Toole JF, et al. Individuals with mutations in XPNPEP3, which encodes a mitochondrial protein, develop a nephronophthisis-like nephropathy. J Clin Invest. 2010;120(3):791-802.
93. Gieger C, et al. New gene functions in megakaryopoiesis and platelet formation. Nature. 2011;480(7376):201-208.
94. Adatto I, Lawrence C, Thompson M, Zon LI. A new system for the rapid collection of large numbers of developmentally staged zebrafish embryos. PLoS One. 2011;6(6):e21715.
95. Tan JL, Zon LI. Chemical screening in zebrafish for novel biological and therapeutic discovery. Methods Cell Biol. 2011;105:493-516.
96. North TE, et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature. 2007;447(7147):1007-1011. (Pubitemid 46975751)
97. White RM, et al. DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature. 2011;471(7339):518-522.
98. Goessling W, et al. Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell. 2009;136(6):1136-1147.
99. Goessling W, et al. Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models. Cell Stem Cell. 2011;8(4):445-458.
100. Mizuno T, Shinya M, Takeda H. Cell and tissue transplantation in zebrafish embryos. Methods Mol Biol. 1999;127:15-28.
101. Xu Q, Stemple D, Joubin K. Microinjection and cell transplantation in zebrafish embryos. Methods Mol Biol. 2008;461:513-520.
102. Stoletov K, Montel V, Lester RD, Gonias SL, Klemke R. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc Natl Acad Sci U S A. 2007;104(44):17406-17411. (Pubitemid 350219851)
103. Taylor AM, Zon LI. Zebrafish tumor assays: the state of transplantation. Zebrafish. 2009;6(4):339-346.
104. Diez-Torre A, et al. Reprogramming of melanoma cells by embryonic microenvironments. Int J Dev Biol. 2009;53(8-10):1563-1568.
105. Haldi M, Ton C, Seng WL, McGrath P. Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish. Angiogenesis. 2006;9(3):139-151. (Pubitemid 46232205)
106. Lee LM, Seftor EA, Bonde G, Cornell RA, Hendrix MJ. The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation. Dev Dyn. 2005;233(4):1560-1570. (Pubitemid 40995154)
107. Nicoli S, Ribatti D, Cotelli F, Presta M. Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Cancer Res. 2007;67(7):2927- 2931. (Pubitemid 46724826)
108. Topczewska JM, et al. Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nat Med. 2006;12(8):925-932. (Pubitemid 44175144)
109. Wenner M. The most transparent research. Nat Med. 2009;15(10):1106-1109.
110. White RM, et al. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell. 2008;2(2):183-189. (Pubitemid 351168711)
111. Ignatius MS, Langenau DM. Fluorescent imaging of cancer in zebrafish. Methods Cell Biol. 2011;105:437-459.
112. Stoletov K, Montel V, Lester RD, Gonias SL, Klemke R. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc Natl Acad Sci U S A. 2007;104(44):17406-17411. (Pubitemid 350219851)